LIVIVO - Search results -

Search results

Result 1 - 10 of total 68

Search options

Book ; Conference proceedings: Asian plants with unique horticultural potential

Lee, Jung-Myung

genetic resources, cultural practices, and utilization ; a proceedings of the XXVI International Horticultural Congress ; Toronto, Canada, 11 - 17 August, 2002

(Acta horticulturae ; 620)

2003

Institution	Canadian Society for Horticultural Science
Event/congress	International Horticultural Congress (26, 2002, Toronto) ; Symposium on Asian Plants with Unique Horticultural Potential (2002, Toronto)
Author's details	organizing Societies: Canadian Society for Horticultural Science ... [Symposium on "Asian Plants with Unique Horticultural Potential: Genetic Resources, Cultural Practices, and Utilization". Volume ed.:] Jung-Myung Lee
Series title	Acta horticulturae ; 620
Collection
Language	English
Size	478 S. : Ill., graph. Darst., Kt.
Publisher	ISHS
Publishing place	Leuven
Publishing country	Belgium
Document type	Book ; Conference proceedings
HBZ-ID	HT013928082
ISBN	90-6605-400-X ; 978-90-6605-400-4
Database	Catalogue ZB MED Nutrition, Environment, Agriculture

In stock of ZB MED Bonn / Germany

Shelf mark	Loan status	Location
048/116	available for loan (reading room)	Freihandmagazin (U1)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- See ZB MED holdings
- Order with fees

Book ; Conference proceedings: International Symposium on Quality of Fresh and Fermented Vegetables

Lee, Jung-Myung

Seoul, Korea 27 - 30, October, 1997

(Acta Horticulturae ; 483)

1999

Title variant	Proceedings of the International Symposium on Quality of Fresh and Fermented Vegetables
Institution	Han'guk-Wŏnye-Hakhoe
Event/congress	International Symposium on Quality of Fresh and Fermented Vegetables (1997, Seoul)
Author's details	Korean Society for Horticultural Science ... Convener: Jung-Myung Lee
Series title	Acta Horticulturae ; 483 Acta horticulturae
Collection	Acta horticulturae
Keywords	Gemüse ; Qualität ; Nachernteverfahren ; Gegorenes Lebensmittel
Subject	Gemüsepflanze ; Gemüsepflanzen ; Nacherntebehandlung ; Nacherntetechnologie ; Produktqualität
Language	English
Size	436 S. : Ill., graph. Darst.
Publisher	ISHS
Publishing place	Leuven
Publishing country	Belgium
Document type	Book ; Conference proceedings
HBZ-ID	HT010608386
ISBN	90-6605-771-8 ; 978-90-6605-771-5
Database	Catalogue ZB MED Nutrition, Environment, Agriculture

In stock of ZB MED Bonn / Germany

Shelf mark	Loan status	Location
998/1142	available for loan (reading room)	Freihandmagazin (U1)

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Left Atrial Remodeling and Thromboembolic Risk in Patients With Atrial Fibrillation.

Chung, Hyemoon / Lee, Jung Myung

International journal of heart failure

2022 Volume 4, Issue 1, Page(s) 26–28

Language	English
Publishing date	2022-01-31
Publishing country	Korea (South)
Document type	Editorial
ISSN	2636-1558
ISSN (online)	2636-1558
DOI	10.36628/ijhf.2022.0006
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Book ; Conference proceedings: Proceedings of the International Symposium on Horticultural Plants in Urban and Peri-Urban Life

Lee, Jung-Myung / Lumpkin, Thomas A.

Seoul, Korea, August 13 - 19, 2006

(Acta horticulturae ; 762)

2007

Institution	International Society for Horticultural Science / Education Commission
Event/congress	International Symposium on Horticultural Plants in Urban and Peri-Urban Life (2006, Seoul) ; International Horticultural Congress (27, 2006, Seoul)
Author's details	ISHS Commission Education, Research Training and Consultancy ... [Ed.: T. A. Lumpkin ... ]; Conveners: J.-M. Lee
Series title	Acta horticulturae ; 762
Collection
Language	English
Size	448 S. : Ill., graph. Darst., Kt.
Publisher	ISHS
Publishing place	Leuven
Publishing country	Belgium
Document type	Book ; Conference proceedings
HBZ-ID	HT015464562
ISBN	978-90-6605-700-5 ; 90-6605-700-9
Database	Catalogue ZB MED Nutrition, Environment, Agriculture

In stock of ZB MED Bonn / Germany

Shelf mark	Loan status	Location
088/321	available for loan (reading room)	Freihandmagazin (U1)

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- See ZB MED holdings
- Order with fees

Article: Efficacy and Safety of Da-Chai-Hu-Tang in Lipid Profiles in High-Risk, Statin-Treated Patients with Residual HyperTG: A 12-Week, Randomized, Active-Control, Open Clinical Study.

Lee, Young-Shin / Lee, Jung-Myung / Chung, Hyemoon / Woo, Jong-Shin / Lee, Byung-Cheol / Kim, Weon

Life (Basel, Switzerland)

2022 Volume 12, Issue 3

Abstract: Da-Chai-Hu-Tang (DCHT) is a herbal extract that has been shown to reduce serum triglyceride (TG) levels in animal experiments as well as small clinical trials. This study aimed to evaluate the efficacy and safety of DCHT in high-risk, statin-treated ... ...

Abstract	Da-Chai-Hu-Tang (DCHT) is a herbal extract that has been shown to reduce serum triglyceride (TG) levels in animal experiments as well as small clinical trials. This study aimed to evaluate the efficacy and safety of DCHT in high-risk, statin-treated patients with residual hypertriglyceridemia (hyperTG). This was a 12-week, randomized, active-controlled, open-label, single-center trial. Of these patients, 42 had high cardiovascular risks whose LDL cholesterol levels were controlled by statin treatment; however, with TG levels of 200 to 500 mg/dL they were randomly assigned 1:1 to the OMEGA3 or DCHT group. The primary endpoint was defined as the percentage change in TG at 12 weeks, and changes in other lipid profiles and endothelial cell function were included as secondary endpoints. Safety analyses were also conducted. In the OMEGA3 group, the average TG level decreased from 294.5 ± 72.0 to 210.0 ± 107.8 mg/dL (
Language	English
Publishing date	2022-03-11
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2662250-6
ISSN	2075-1729
ISSN	2075-1729
DOI	10.3390/life12030408
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Performance and Physician Experience of INGEVITY+ Active Fixation Leads: Prospective INGEVITY+ Lead Clinical Study in Korea.

Joung, Boyoung / Bae, Myung Hwan / Oh, Il-Young / Park, Hyung-Seob / Shim, Jaemin / Cho, Min Soo / Lee, Jung Myung / Choi, Eue-Keun / Lee, Young Soo

Cardiology research and practice

2024 Volume 2024, Page(s) 2172306

Abstract: Background: Boston Scientific INGEVITY+ pacing lead (Boston Scientific, Marlborough, MA, USA) has been upgraded to INGEVITY. The performance of the INGEVITY+ pacing lead has not yet been reported. This study aimed to evaluate the short- and long-term ... ...

Abstract	Background: Boston Scientific INGEVITY+ pacing lead (Boston Scientific, Marlborough, MA, USA) has been upgraded to INGEVITY. The performance of the INGEVITY+ pacing lead has not yet been reported. This study aimed to evaluate the short- and long-term safety, effectiveness, and handling experience of INGEVITY+ leads. Methods: Consecutive patients were included from 9 institutions in Korea, where 400 leads (200 right ventricular active fixation leads and 200 right atrial active fixation leads) were implanted or attempted in 200 subjects. Results: During the implantation, only one patient required a lead change because of lead screw failure. The handling questionnaires of the lead received very positive feedback with 88% of operators agreeing that it is easy for leads to pass through small vessels or vessels with multiple leads. At the 3-month follow-up, 95.7% of RA leads and 99.5% of RV leads had pacing thresholds less than 1.5 V. A total of 92.4% of atrial leads had amplitudes greater than 1.5 mV, and 96.5% of ventricular leads had sensing amplitudes greater than 5 mV at 3 months. A total of 99.8% had impedances between 300 and 1,300 ohms. The lead-related complication-free rate for all leads during follow-up was 100%, and the overall rates of lead dislodgment, perforation, and pericardial effusion were all 0.0%. Conclusions: The INGEVITY+ pacing lead exhibited exceptional clinical performance, with a high complication-free rate throughout the 3-month follow-up period. In addition, the lead displayed excellent electrical characteristics, and the lead-handling experience was reported to be very good.
Language	English
Publishing date	2024-01-11
Publishing country	United States
Document type	Journal Article
ZDB-ID	2506187-2
ISSN	2090-0597 ; 2090-8016
ISSN (online)	2090-0597
ISSN	2090-8016
DOI	10.1155/2024/2172306
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Primary Cardiac Lymphoma Manifesting as an Atrioventricular Block in a Renal Transplantation Recipient.

Jang, Gyeong-Won / Chung, Hyemoon / Kim, Woo-Shik / Lee, Jung Myung

JACC. Case reports

2020 Volume 2, Issue 4, Page(s) 600–603

Abstract: Our report illustrates an atrioventricular block due to primary cardiac lymphoma attached to the right atrial septum that was rapidly reversible by surgical debulking and effective chemotherapy without the need for a permanent pacemaker. ( ...

Abstract	Our report illustrates an atrioventricular block due to primary cardiac lymphoma attached to the right atrial septum that was rapidly reversible by surgical debulking and effective chemotherapy without the need for a permanent pacemaker. (
Language	English
Publishing date	2020-04-15
Publishing country	Netherlands
Document type	Case Reports
ISSN	2666-0849
ISSN (online)	2666-0849
DOI	10.1016/j.jaccas.2020.01.028
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Comparison of the Effects of High-intensity Statin Therapy with Moderate-Intensity Statin and Ezetimibe Combination Therapy on Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction: a Nationwide Cohort Study.

Kim, Kihyun / Bang, Woo-Dae / Han, Kyungdo / Kim, Bongseong / Lee, Jung Myung / Chung, Hyemoon

Journal of lipid and atherosclerosis

2021 Volume 10, Issue 3, Page(s) 291–302

Abstract: Objective: We compared the effects of high-intensity statin monotherapy versus moderate-intensity statin and ezetimibe combination therapy on major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI).: Methods: ... ...

Abstract	Objective: We compared the effects of high-intensity statin monotherapy versus moderate-intensity statin and ezetimibe combination therapy on major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI). Methods: Using the Korean National Health Insurance Service database, we screened 82,941 patients with AMI who underwent percutaneous coronary intervention (PCI) between 2013 and 2016. Among them, we identified 9,908 patients treated with atorvastatin 40 mg (A40, n=4,041), atorvastatin 20 mg + ezetimibe 10 mg (A20+E10, n=233), rosuvastatin 20 mg (R20, n=5,251), or rosuvastatin 10 mg + ezetimibe 10 mg (R10+E10, n=383). The primary outcome was MACE, a composite of all-cause death, non-fatal myocardial infarction undergoing PCI, repeat revascularization, and ischemic stroke. Multivariable analyses were performed using the inverse probability of treatment weighting method. Results: The incidence rate of MACE in the overall population was 42.97 cases per 1,000 person-years. There was no significant difference in the risk of composite outcomes of MACE between the groups. However, the R10+E10 group showed a higher risk of all-cause death (hazard ratio, 2.07; 95% confidence interval, 1.08-3.94) than the A40 group (reference group) in the weighted multivariable model. Conclusions: In this study, there was no significant difference in the composite outcome of MACE between high-intensity statin monotherapy and moderate-intensity statin and ezetimibe combination therapy.
Language	English
Publishing date	2021-05-25
Publishing country	Korea (South)
Document type	Journal Article
ZDB-ID	3016001-7
ISSN	2288-2561 ; 2287-2892
ISSN (online)	2288-2561
ISSN	2287-2892
DOI	10.12997/jla.2021.10.3.291
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized Controlled Trial.

Cho, Jeong Gwan / Lee, Ki Hong / Kim, Yoo Ri / Kim, Sunah / Gwak, Jisoo / Cho, Eunbit / Sin, Yourim / Shin, Seung Yong / Park, Hyung Wook / Ko, Jum Suk / Kim, Nam Ho / Park, Yae Min / Lee, Jung Myung / Yoon, Nam Sik / Kim, Sung Soo / Kim, Jun Hyung / Kim, Dong Min

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

2023 Volume 29, Page(s) 10760296231171081

Abstract: Anticoagulation with warfarin in Asian patients with atrial fibrillation (AF) often has been decreased as an international normalized ratio (INR) of prothrombin time 1.6-2.6 due to fear of bleeding, although universal criteria recommend an INR of 2.0-3.0. ...

Abstract	Anticoagulation with warfarin in Asian patients with atrial fibrillation (AF) often has been decreased as an international normalized ratio (INR) of prothrombin time 1.6-2.6 due to fear of bleeding, although universal criteria recommend an INR of 2.0-3.0. In this randomized, open-label trial, low-intensity anticoagulation (INR 1.6-2.6) was compared with standard-intensity anticoagulation (INR 2.0-3.0) with warfarin. A total 616 patients with AF and at least 1 risk factor for stroke were randomized to low-intensity anticoagulation (n = 308) and standard-intensity anticoagulation (n = 308) groups. The intention-to-treat analysis was performed to determine differences. The baseline characteristics of the two groups were comparable. New-onset stroke occurred in 2 patients (0.44% per year) in the low-intensity group and 5 patients (1.05% per year) in the standard-intensity group (HR 0.42, 95% CI 0.08-2.15). Major bleeding occurred in 4 patients (0.89% per year) in the low-intensity group and 5 patients (1.06% per year) in the standard-intensity group (HR 0.84, 95% CI 0.22-3.11). The rate of the net clinical outcome (composite of stroke, systemic embolism, major bleeding, and death) was 1.33% per year in the low-intensity group compared with 2.12% per year in the standard-intensity group (HR 0.63, 95% CI 0.23-1.72). In Asian patients with AF, clinical outcomes were not different between low-intensity and standard-intensity anticoagulation with warfarin.
MeSH term(s)	Humans ; Warfarin/adverse effects ; Atrial Fibrillation/drug therapy ; Atrial Fibrillation/complications ; Anticoagulants/therapeutic use ; Stroke/prevention & control ; Stroke/chemically induced ; Hemorrhage/chemically induced ; Hemorrhage/drug therapy
Chemical Substances	Warfarin (5Q7ZVV76EI) ; Anticoagulants
Language	English
Publishing date	2023-04-20
Publishing country	United States
Document type	Randomized Controlled Trial ; Multicenter Study ; Journal Article
ZDB-ID	1237357-6
ISSN	1938-2723 ; 1076-0296
ISSN (online)	1938-2723
ISSN	1076-0296
DOI	10.1177/10760296231171081
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4370: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.

Lee, Kyuhyun / Lee, Soo Kyoung / Lee, Juyeon / Jeon, Bo Kyung / Kim, Tae-Hoon / Yu, Hee Tae / Lee, Jung Myung / Park, Jin-Kyu / Baek, Yong-Soo / Kim, Dong Hyeok / Shim, Jaemin / Joung, Boyoung / Lee, Moon-Hyoung / Pak, Hui-Nam / Park, Junbeom

PloS one

2023 Volume 18, Issue 1, Page(s) e0280359

Abstract: SGLT-2 inhibitor, traditionally used for glycemic control, has several beneficial effects that can help manage heart failure (HF). SGLT-2 inhibitors reduce the risk of cardiovascular mortality in patients with HF. As atrial fibrillation (AF) is closely ... ...

Abstract	SGLT-2 inhibitor, traditionally used for glycemic control, has several beneficial effects that can help manage heart failure (HF). SGLT-2 inhibitors reduce the risk of cardiovascular mortality in patients with HF. As atrial fibrillation (AF) is closely associated with HF and diabetes mellitus (DM) is a risk factor for AF, we assume that SGLT-2 inhibitors will also show therapeutic benefits regarding AF, especially for rhythm control. This trial has a multicenter, prospective, open, blinded endpoint design. It is a 1:1 randomized and controlled study. A total of 716 patients who are newly diagnosed of AF and DM within 1 year will be enrolled from 7 tertiary medical centers. The trial is designed to compare the effects of SGLT-2 inhibitors and other oral hypoglycemic agents on atrial rhythm control in patients with AF and DM. The primary outcome is the recurrence of AF within a year (including post-antiarrhythmic drugs (AAD) or ablation). The secondary outcomes are the ablation rate within a year, change in AF burden, size of the left atrium, NT-proBNP, the AF symptom score, and the quality of life. This trial will prospectively evaluate the effect and safety of SGLT-2 inhibitors on AF rhythm control in patients with DM. It will provide an invaluable dataset on rhythm control in AF with DM for future studies and offer novel information to assist in clinical decisions. (BEYOND trial, ClinicalTrials.gov number: NCT05029115. https://clinicaltrials.gov/ct2/show/NCT05029115).
MeSH term(s)	Humans ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Prospective Studies ; Quality of Life ; Heart Failure ; Diabetes Mellitus/etiology ; Glucose/therapeutic use ; Sodium ; Treatment Outcome ; Catheter Ablation/methods ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Chemical Substances	Sodium-Glucose Transporter 2 Inhibitors ; Glucose (IY9XDZ35W2) ; Sodium (9NEZ333N27)
Language	English
Publishing date	2023-01-18
Publishing country	United States
Document type	Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2267670-3
ISSN	1932-6203 ; 1932-6203
ISSN (online)	1932-6203
ISSN	1932-6203
DOI	10.1371/journal.pone.0280359
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

To top

More links

Kategorien

In stock of ZB MED Bonn / Germany

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Bonn / Germany

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Bonn / Germany

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito